Atea Pharmaceuticals is trading at $4.38, up +5.04%, alongside a strong broader-market session.
- Major U.S. indexes are higher; no clear company-specific catalyst for the move was identified.
- The company’s third-quarter results and business update call is scheduled for November 9, not November 4.